Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.

Pile of papers with bright paperclips © Shutterstock

The living reviews will summarise literature around one topic and are a response to the speed and volume of COVID-19 immunology research published during the pandemic.

On behalf of the Oxford-Cardiff COVID-19 Literature Consortium, Dr Ewoud Compeer, University of Oxford points out the idea behind this new publishing format: "The field of COVID-19 immunology was seeing new developments and new hypotheses appearing at an extreme pace online in the form of pre-prints. This speed of publishing made literature reviews outdated even before a journal published them. Our 'living reviews' will stay "live" for a designated period, being updated as change happens."

The journal publishes peer reviewed scientific articles, and the annotation enables rapid communication of updated information, but the version of record does not change so provides a history of the scientific developments.

Professor Awen Gallimore, Cardiff University finds similar advantages to the 'live' format of reviews: "Because new information emerges day by day, when you publish something on Monday by the following Friday it may already be out of date. Our living reviews enable as-you-go updates and should represent a useful step towards supporting scientists address the big and trending research questions."

The COVID-19 Literature initiative began with a team of around 100 post-doctoral researchers, DPhil students, and faculty members from the Medical Sciences Division at the University of Oxford reading, reviewing and summarising the latest COVID-19 research from all round the world in order to support frontline researchers.

At Cardiff, the School of Medicine-wide Journal Club, also comprising PhD students, post-docs and ECRs had started a similar initiative. Oxford and Cardiff joined forces to pool expertise around a wider range of disciplines and ensure those on the frontline were up to date with the latest developments in the field.

The living reviews add to a growing body of material from the Oxford-Cardiff COVID-19 Literature Consortium that is available through their website, and popular science blog, and could become a new benchmark for reviewing research in the future.

"We are pleased to be able to support the research community with this new series of Living Reviews from the Oxford-Cardiff COVID-19 Literature Consortium. We're excited to be able to offer this new open annotation functionality to our authors in Oxford Open Immunology and hope that this innovative new format will generate a useful and up to date resource for readers," said Rhiannon Meaden, Senior Publisher at OUP.

"The reviews were like a paint-by-numbers, we knew there were bits missing and new colours were coming in week by week, but it would be years before we got the whole picture," said Luke Davies from Cardiff University, one of the authors of the first published review. "A living review allows us to carefully add to the picture over time, while still delivering an up-to-date snapshot of the field that can aid ongoing research."

The first living reviews to be published are: Viral entry, sensing and evasion, and Dysregulated inflammation drives immunopathology.

 

 

Similar stories

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Professor Keith Willett recognised in Queen’s Birthday Honours

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

Professor Dani Prieto-Alhambra elected to ISPE Board of Directors

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.

New research from the Kennedy Institute of Rheumatology identifies a role for CD200 in limiting atherosclerosis

A new study published in Circulation Research shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.

EPSRC funds research to avert an antibiotics apocalypse

Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.

Research finds that surgery for Dupuytren’s disease is effective, but repeat operations come with higher risks

Research by NDORMS Dominic Furniss, Professor of Plastic and Reconstructive Surgery, finds that surgery for the common hand disorder Dupuytren’s disease is safe and effective. However, repeat surgery could carry higher risks of complications such as finger amputation.